---
category: news
title: "Kiromic BioPharma Announces Strategic Collaboration with Gemelli Teaching Hospital to Accelerate the Analysis of Allogeneic CAR-T Clinical Trial Candidate Alexis ISO-1 in Solid ..."
excerpt: "Alexis ISO-1 is Companyâ€™s First Artificial Intelligence-identified, Gamma Delta T Cell Engineered Iso-Mesothelin Candidate to Address Solid Tumor Cancers HOUSTON-- ( BUSINESS WIRE )--Kiromic BioPharma,"
publishedDateTime: 2021-10-11T16:02:00Z
originalUrl: "https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers"
webUrl: "https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers"
type: article
quality: 0
heat: 0
published: false

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI in Healthcare
  - AI

secured: "fEPrM54IcR28UVacKCI/tIvT86G/Lrdy/NbLZha0IAnDaLmsFyTq6AE7IaRghZuB+jckzQ5wDEln/K57+xt+lHO3JVMrf/15RsH6HpN83cgfthjKUI3rUiauGYHjtD3UDSNLYWZ0Bi0SMavaZAfAZewg3pL3GJOLMi1gpp+FsIHRuXIq9OGw/jtmnzN7i1KO1u4aUE5F3U0uTWYU72WQ6GYb6PRRJWlMppQHlhXe0dc/Gyt2nKNG4pNKhdCiF3gL51cFSnmaDcd7TYbKrMDP4DN1pSICOT5hKXF/pH3Bwd2Rw4Bp9/AkFq5FqQXYrQiFZyuSKLNsVsWNQILtGiRtH4CV5KXSyaAwO2qNmlBYlIg=;tlRGOdJijs6u03w0BhYWBQ=="
---

